Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Bernstein

Showing results (131-140 of 141) with videos related to

Pageof 15
Sort By:
The Journal of Allergy and Clinical Immunology|April 5, 2011
Stinging insect hypersensitivity: a practice parameter update 2011David B K Golden, John Moffitt, Richard A Nicklas, et al.
American Journal of Respiratory and Critical Care Medicine|January 13, 2009
A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthmaSally E Wenzel, Peter J Barnes, Eugene R Bleecker, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 27, 2012
Environmental assessment and exposure reduction of rodents: a practice parameterWanda Phipatanakul, Elizabeth Matsui, Jay Portnoy, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|October 28, 2015
Anaphylaxis--a practice parameter update 2015Phillip Lieberman, Richard A Nicklas, Christopher Randolph, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 26, 2013
Environmental assessment and exposure control of dust mites: a practice parameterJay Portnoy, Jeffrey D Miller, P Brock Williams, et al.
Gastroenterology|August 4, 2016
Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Hepatitis C Virus Genotype 2, 3, 4, or 6 Infections in an Open-Label, Phase 2 TrialEdward J Gane, Kris V Kowdley, David Pound, et al.
The New England Journal of Medicine|May 6, 2014
ABT-450/r-ombitasvir and dasabuvir with or without ribavirin for HCVPeter Ferenci, David Bernstein, Jacob Lalezari, et al.
Hepatology (Baltimore, Md.)|January 24, 2015
All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III studyDavid R Nelson, James N Cooper, Jacob P Lalezari, et al.
European Journal of Cancer (Oxford, England : 1990)|July 13, 2021
Dose-escalated intensity-modulated radiotherapy in patients with locally advanced laryngeal and hypopharyngeal cancers: ART DECO, a phase III randomised controlled trialChristopher M Nutting, Clare L Griffin, Paul Sanghera, et al.
Pancreas|April 9, 2021
Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative ReviewBarbara Kenner, Suresh T Chari, David Kelsen, et al.
Pageof 15

Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
The Journal of Allergy and Clinical Immunology|April 5, 2011
Stinging insect hypersensitivity: a practice parameter update 2011David B K Golden, John Moffitt, Richard A Nicklas, et al.
American Journal of Respiratory and Critical Care Medicine|January 13, 2009
A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthmaSally E Wenzel, Peter J Barnes, Eugene R Bleecker, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 27, 2012
Environmental assessment and exposure reduction of rodents: a practice parameterWanda Phipatanakul, Elizabeth Matsui, Jay Portnoy, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|October 28, 2015
Anaphylaxis--a practice parameter update 2015Phillip Lieberman, Richard A Nicklas, Christopher Randolph, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 26, 2013
Environmental assessment and exposure control of dust mites: a practice parameterJay Portnoy, Jeffrey D Miller, P Brock Williams, et al.
Gastroenterology|August 4, 2016
Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Hepatitis C Virus Genotype 2, 3, 4, or 6 Infections in an Open-Label, Phase 2 TrialEdward J Gane, Kris V Kowdley, David Pound, et al.
The New England Journal of Medicine|May 6, 2014
ABT-450/r-ombitasvir and dasabuvir with or without ribavirin for HCVPeter Ferenci, David Bernstein, Jacob Lalezari, et al.
Hepatology (Baltimore, Md.)|January 24, 2015
All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III studyDavid R Nelson, James N Cooper, Jacob P Lalezari, et al.
European Journal of Cancer (Oxford, England : 1990)|July 13, 2021
Dose-escalated intensity-modulated radiotherapy in patients with locally advanced laryngeal and hypopharyngeal cancers: ART DECO, a phase III randomised controlled trialChristopher M Nutting, Clare L Griffin, Paul Sanghera, et al.
Pancreas|April 9, 2021
Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative ReviewBarbara Kenner, Suresh T Chari, David Kelsen, et al.
Pageof 15